Jeremy L Ross1, Sirinya Teeraananchai2, Pagakrong Lumbiganon3, Rawiwan Hansudewechakul4, Kulkanya Chokephaibulkit5, Truong Huu Khanh6, Lam Van Nguyen7, Thahira A Jamal Mohamed8, Nik Khairulddin Nik Yusoff9, Moy Siew Fong10, Wasana Prasitsuebsai2, Annette H Sohn1, Stephen J Kerr2,11. 1. TREAT Asia/amfAR, The Foundation for AIDS Research, Bangkok, Thailand. 2. The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT), The Thai Red Cross AIDS Research Centre, Bangkok, Thailand. 3. Faculty of Medicine, Srinagarind Hospital, Khon Kaen University, Khon Kaen, Thailand. 4. Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand. 5. Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. 6. Children's Hospital 1, Ho Chi Minh City, Vietnam. 7. National Hospital of Pediatrics, Hanoi, Vietnam. 8. Pediatric Institute, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia. 9. Hospital Raja Perempuan Zainab II, Kelantan, Malaysia. 10. Hospital Likas, Kota Kinabalu, Malaysia. 11. Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Abstract
BACKGROUND: Adolescents living with HIV (ALHIV) have poorer adherence and clinical outcomes than adults. We conducted a study to assess behavioral risks and antiretroviral therapy outcomes among ALHIV in Asia. METHODS: A prospective cohort study among ALHIV and matched HIV-uninfected controls aged 12-18 years was conducted at 9 sites in Malaysia, Thailand, and Vietnam from July 2013 to March 2017. Participants completed an audio computer-assisted self-interview at weeks 0, 48, 96, and 144. Virologic failure (VF) was defined as ≥1 viral load (VL) measurement >1000 copies/mL. Generalized estimating equations were used to identify predictors for VF. RESULTS: Of 250 ALHIV and 59 HIV-uninfected controls, 58% were Thai and 51% females. The median age was 14 years at enrollment; 93% of ALHIV were perinatally infected. At week 144, 66% of ALHIV were orphans vs. 28% of controls (P < 0.01); similar proportions of ALHIV and controls drank alcohol (58% vs. 65%), used inhalants (1% vs. 2%), had been sexually active (31% vs. 21%), and consistently used condoms (42% vs. 44%). Of the 73% of ALHIV with week 144 VL testing, median log VL was 1.60 (interquartile range 1.30-1.70) and 19% had VF. Over 70% of ALHIV had not disclosed their HIV status. Self-reported adherence ≥95% was 60% at week 144. Smoking cigarettes, >1 sexual partner, and living with nonparent relatives, a partner or alone, were associated with VF at any time. CONCLUSIONS: The subset of ALHIV with poorer adherence and VF require comprehensive interventions that address sexual risk, substance use, and HIV-status disclosure.
BACKGROUND: Adolescents living with HIV (ALHIV) have poorer adherence and clinical outcomes than adults. We conducted a study to assess behavioral risks and antiretroviral therapy outcomes among ALHIV in Asia. METHODS: A prospective cohort study among ALHIV and matched HIV-uninfected controls aged 12-18 years was conducted at 9 sites in Malaysia, Thailand, and Vietnam from July 2013 to March 2017. Participants completed an audio computer-assisted self-interview at weeks 0, 48, 96, and 144. Virologic failure (VF) was defined as ≥1 viral load (VL) measurement >1000 copies/mL. Generalized estimating equations were used to identify predictors for VF. RESULTS: Of 250 ALHIV and 59 HIV-uninfected controls, 58% were Thai and 51% females. The median age was 14 years at enrollment; 93% of ALHIV were perinatally infected. At week 144, 66% of ALHIV were orphans vs. 28% of controls (P < 0.01); similar proportions of ALHIV and controls drank alcohol (58% vs. 65%), used inhalants (1% vs. 2%), had been sexually active (31% vs. 21%), and consistently used condoms (42% vs. 44%). Of the 73% of ALHIV with week 144 VL testing, median log VL was 1.60 (interquartile range 1.30-1.70) and 19% had VF. Over 70% of ALHIV had not disclosed their HIV status. Self-reported adherence ≥95% was 60% at week 144. Smoking cigarettes, >1 sexual partner, and living with nonparent relatives, a partner or alone, were associated with VF at any time. CONCLUSIONS: The subset of ALHIV with poorer adherence and VF require comprehensive interventions that address sexual risk, substance use, and HIV-status disclosure.
Authors: Nhung T P Nguyen; Bach X Tran; Lu Y Hwang; Christine M Markham; Michael D Swartz; Jennifer I Vidrine; Huong T T Phan; Carl A Latkin; Damon J Vidrine Journal: AIDS Care Date: 2015-10-13
Authors: Katherine S Elkington; José A Bauermeister; Reuben N Robbins; Olga Gromadzka; Elaine J Abrams; Andrew Wiznia; Mahrukh Bamji; Claude A Mellins Journal: AIDS Patient Care STDS Date: 2012-06-13 Impact factor: 5.078
Authors: Julie Alperen; Sean Brummel; Katherine Tassiopoulos; Claude A Mellins; Deborah Kacanek; Renee Smith; George R Seage; Anna-Barbara Moscicki Journal: J Adolesc Health Date: 2013-11-13 Impact factor: 5.012
Authors: Kiran Jobanputra; Lucy Anne Parker; Charles Azih; Velephi Okello; Gugu Maphalala; Bernard Kershberger; Mohammed Khogali; Johnny Lujan; Annick Antierens; Roger Teck; Tom Ellman; Rose Kosgei; Tony Reid Journal: PLoS One Date: 2015-02-19 Impact factor: 3.240
Authors: Katharina Kranzer; John Bradley; Joseph Musaazi; Mary Nyathi; Hilary Gunguwo; Wedu Ndebele; Mark Dixon; Mbongeni Ndhlovu; Andrea Rehman; Palwasha Khan; Florian Vogt; Tsitsi Apollo; Rashida Abbas Ferrand Journal: J Int AIDS Soc Date: 2017-07-17 Impact factor: 5.396
Authors: Philippe R Mutwa; Jennifer Ilo Van Nuil; Brenda Asiimwe-Kateera; Evelyne Kestelyn; Joseph Vyankandondera; Robert Pool; John Ruhirimbura; Chantal Kanakuze; Peter Reiss; Sibyl Geelen; Janneke van de Wijgert; Kimberly R Boer Journal: PLoS One Date: 2013-04-03 Impact factor: 3.240
Authors: Ali Judd; Diane Melvin; Lindsay C Thompson; Caroline Foster; Marthe Le Prevost; Michael Evangeli; Alan Winston; Alejandro Arenas-Pinto; Kate Sturgeon; Katie Rowson; Diana M Gibb; Hannah Castro Journal: J Assoc Nurses AIDS Care Date: 2020 Sep-Oct Impact factor: 1.354